How are AI and intellectual property advancing precision healthcare?

In this interview, Xiang Jianping, founder and CEO of Hangzhou ArteryFlow Technology, shares the company's AI-powered solutions for cardiovascular and cerebrovascular diseases, its IP strategy and what winning a 2026 WIPO Global Award means for its innovation journey.

Discover more in the full interview.